Targeting cellular energy production in neurological disorders
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
The concepts of energy dysregulation and oxidative stress and their complicated interdependence have rapidly evolved to assume primary importance in understanding the pathophysiology of numerous neurological disorders. Therefore, neuroprotective strategies addressing specific bioenergetic defects hold particular promise in the treatment of these conditions (i.e., amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, Friedreich's ataxia, mitochondrial cytopathies and other neuromuscular diseases), all of which, to some extent, share 'the final common pathway' leading to cell death through either necrosis or apoptosis. Compounds such as creatine monohydrate and coenzyme Q(10) offer substantial neuroprotection against ischaemia, trauma, oxidative damage and neurotoxins. Miscellaneous agents, including alpha-lipoic acid, beta-OH-beta-methylbutyrate, riboflavin and nicotinamide, have also been shown to improve various metabolic parameters in brain and/or muscle. This review will highlight the biological function of each of the above mentioned compounds followed by a discussion of their utility in animal models and human neurological disease. The balance of this work will be comprised of discussions on the therapeutic applications of creatine and coenzyme Q(10).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Superoxide activates mitochondrial uncoupling proteins
Echtay, K. S., Roussel, D., St-Pierre, J., Jekabsons, M. B., Cadenas, S., Stuart, J. A., Harper, J. A., Roebuck, S. J., Morrison, A., Pickering, S., et al. (2002) · Nature · doi:10.1038/415096a · Cited by 1,382
Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins
Wood, I. S., & Trayhurn, P. (2003) · British Journal of Nutrition · doi:10.1079/bjn2002763 · Cited by 889
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Biochemical Functions of Coenzyme Q 10
Crane, F. L. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719063 · Cited by 869
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Bogdanis, G. C., Nevill, M. E., Boobis, L. H., & Lakomy, H. K. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.80.3.876 · Cited by 691
Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8892 · Cited by 557
Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Greenhaff, P. L., Casey, A., Short, A. H., Harris, R., Soderlund, K., & Hultman, E. (1993) · Clinical Science · doi:10.1042/cs0840565 · Cited by 460
Direct antioxidant properties of creatine
Lawler, J. M., Barnes, W. S., Wu, G., Song, W., & Demaree, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6164 · Cited by 448
Recovery of power output and muscle metabolites following 30 s of maximal sprint cycling in man
Bogdanis, G. C., Nevill, M. E., Boobis, L. H., Lakomy, H. K., & Nevill, A. M. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020533 · Cited by 431
Long-term creatine intake is beneficial to muscle performance during resistance training
Vandenberghe, K., Goris, M., Van Hecke, P., Van Leemputte, M., Vangerven, L., & Hespel, P. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.6.2055 · Cited by 430
Good, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Therapeutic Effects of Coenzyme Q10and Remacemide in Transgenic Mouse Models of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Dedeoglu, A., Ferrante, K. L., Jenkins, B. G., Hersch, S. M., & Beal, M. F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01592.2002 · Cited by 391
Mandir, A. S., Przedborski, S., Jackson-Lewis, V., Wang, Z.-Q., Simbulan-Rosenthal, C. M., Smulson, M. E., Hoffman, B. E., Guastella, D. B., Dawson, V. L., & Dawson, T. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5774 · Cited by 382
Rate of functional decline in Huntington’s disease
Marder, K., Zhao, H., Myers, R. H., Cudkowicz, M., Kayson, E., Kieburtz, K., Orme, C., Paulsen, J., Penney, J. B., Siemers, E., et al. (2000) · Neurology · doi:10.1212/wnl.54.2.452 · Cited by 362
Novel non-heme iron center of nitrile hydratase with a claw setting of oxygen atoms
Nagashima, S., Nakasako, M., Dohmae, N., Tsujimura, M., Takio, K., Odaka, M., Yohda, M., Kamiya, N., & Endo, I. (1998) · Nature Structural Biology · doi:10.1038/nsb0598-347 · Cited by 353
Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420221 · Cited by 326
Ghirlanda, G., Oradei, A., Manto, A., Lippa, S., Uccioli, L., Caputo, S., Greco, A. V., & Littarru, G. P. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03948.x · Cited by 324
Echtay, K. S., Winkler, E., Frischmuth, K., & Klingenberg, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1416 · Cited by 313
A randomized, placebo-controlled trial of coenzyme Q 10 and remacemide in Huntington’s disease
The Huntington Study Group (2001) · Neurology · doi:10.1212/wnl.57.3.397 · Cited by 312
Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., Jenkins, B. G., Ferrante, K. L., Thomas, M., Friedlich, A., Browne, S. E., Schilling, G., Borchelt, D. R., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0406 · Cited by 293
Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy
Arnold, D. L., Taylor, D. J., & Radda, G. K. (1985) · Annals of Neurology · doi:10.1002/ana.410180205 · Cited by 266
DE PINIEUX, G., CHARIOT, P., AMMI‐SAÏD, M., LOUARN, F., LEJONC, J. L., ASTIER, A., JACOTOT, B., & GHERARDI, R. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.04178.x · Cited by 262
Beal, M. F., Matthews, R. T., Tieleman, A., & Shults, C. W. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01192-x · Cited by 256
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Parise, G., Mihic, S., MacLennan, D., Yarasheski, K. E., & Tarnopolsky, M. A. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.3.1041 · Cited by 236
Self-citationBioenergetic approaches for neuroprotection in Parkinson's disease
Beal, M. F. (2003) · Annals of Neurology · doi:10.1002/ana.10479 · Cited by 236
Brewer, G. J., & Wallimann, T. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741968.x · Cited by 230
Vukovich, M. D., Stubbs, N. B., & Bohlken, R. M. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.7.2049 · Cited by 222
Renal dysfunction accompanying oral creatine supplements
Pritchard, N., & Kalra, P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79319-3 · Cited by 213
Panton, L. B., Rathmacher, J. A., Baier, S., & Nissen, S. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00376-2 · Cited by 204
MIHIC, S., MacDONALD, J. R., McKENZIE, S., & TARNOPOLSKY, M. A. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200002000-00007 · Cited by 201
Self-citationCoenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate
Beal, M. F., Henshaw, D. R., Jenkins, B. G., Rosen, B. R., & Schulz, J. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360613 · Cited by 189
Effects of Oral Creatine and Resistance Training on Myogenic Regulatory Factor Expression
WILLOUGHBY, D. S., & ROSENE, J. M. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000069746.05241.f0 · Cited by 186
Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina
Sipilä, I., Rapola, J., Simell, O., & Vannas, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104093041503 · Cited by 181
Sahlin, K., Harris, R. C., & Hultman, E. (1979) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517909108833 · Cited by 180
Laaksonen, R., Jokelainen, K., Sahi, T., Tikkanen, M. J., & Himberg, J.-J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90266-x · Cited by 177
??-hydroxy-??-methylbutyrate ingestion, Part I: effects on strength and fat free mass
GALLAGHER, P. M., CARRITHERS, J. A., GODARD, M. P., SCHULZE, K. E., & TRAPPE, A. S. W. (2000) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200012000-00022 · Cited by 171
Laaksonen, R., Jokelainen, K., Laakso, J., Sahi, T., Härkönen, M., Tikkanen, M. J., & Himberg, J.-J. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89180-1 · Cited by 171
Effect of short-term creatine supplementation on renal responses in men
Poortmans, J. R., Auquier, H., Renaut, V., Durussel, A., Saugy, M., & Brisson, G. R. (1997) · European Journal of Applied Physiology · doi:10.1007/s004210050291 · Cited by 170
Dedeoglu, A., Kubilus, J. K., Yang, L., Ferrante, K. L., Hersch, S. M., Beal, M. F., & Ferrante, A. R. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01706.x · Cited by 169
Schilling, G., Coonfield, M. L., Ross, C. A., & Borchelt, D. R. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02326-6 · Cited by 151
Beneficial effects of creatine supplementation in dystrophic patients
Louis, M., Lebacq, J., Poortmans, J. R., Belpaire‐Dethiou, M., Devogelaer, J., Van Hecke, P., Goubel, F., & Francaux, M. (2003) · Muscle & Nerve · doi:10.1002/mus.10355 · Cited by 130
Stimulatory effect of insulin on creatine accumulation in human skeletal muscle
Steenge, G. R., Lambourne, J., Casey, A., Macdonald, I. A., & Greenhaff, P. L. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.6.e974 · Cited by 125
Cellular energetics of dystrophic muscle
Kemp, G. J., Taylor, D. J., Dunn, J. F., Frostick, S. P., & Radda, G. K. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90326-t · Cited by 125
Gyrate Atrophy of the Choroid and Retina
Vannas-Sulonen, K., Sipilä, I., Vannas, A., Simell, O., & Rapola, J. (1985) · Ophthalmology · doi:10.1016/s0161-6420(85)34098-8 · Cited by 124
Matthews, P. M., Allaire, C., Shoubridge, E. A., Karpati, G., Carpenter, S., & Arnold, D. L. (1991) · Neurology · doi:10.1212/wnl.41.1.114 · Cited by 121
Bendahan, D., Desnuelle, C., Vanuxem, D., Confort-Gouny, S., Figarella-Branger, D., Pellissier, J. F., Kozak-Ribbens, G., Pouget, J., Serratrice, G., & Cozzone, P. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1203 · Cited by 104
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity
Schulz, J. B., Ross Henshaw, D., Matthews, R. T., & Flint Beal, M. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90033-0 · Cited by 103
The regulation of total creatine content in a myoblast cell line
Odoom, J., Kemp, G., & Radda, G. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00225844 · Cited by 101
‘Hot spots’ of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus
Kaldis, P., Hemmer, W., Zanolla, E., Holtzman, D., & Wallimann, T. (2009) · Developmental Neuroscience · doi:10.1159/000111452 · Cited by 99
Adcock, K. H., Nedelcu, J., Loenneker, T., Martin, E., Wallimann, T., & Wagner, B. P. (2002) · Developmental Neuroscience · doi:10.1159/000069043 · Cited by 97
??-hydroxy-??-methylbutyrate ingestion, Part II: effects on hematology, hepatic and renal function
GALLAGHER, P. M., CARRITHERS, J. A., GODARD, M. P., SCHULZE, K. E., & TRAPPE, A. S. W. (2000) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200012000-00023 · Cited by 84
Muscle glycogen supercompensation is enhanced by prior creatine supplementation
NELSON, A. G., ARNALL, D. A., KOKKONEN, J., DAY, R., & EVANS, J. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200107000-00005 · Cited by 79
Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle
Op ‘t Eijnde, B., Richter, E. A., Henquin, J. ‐., Kiens, B., & Hespel, P. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00786.x · Cited by 79
Barisic, N., Bernert, G., Ipsiroglu, O., Stromberger, C., Müller, T., Gruber, S., Prayer, D., Moser, E., Bittner, R. E., & Stöckler-Ipsiroglu, S. (2002) · Neuropediatrics · doi:10.1055/s-2002-33679 · Cited by 66
Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia
Näntö–Salonen, K., Komu, M., Lundbom, N., Heinänen, K., Alanen, A., Sipilä, I., & Simell, O. (1999) · Neurology · doi:10.1212/wnl.53.2.303 · Cited by 63
Protective effects of oral creatine supplementation on spinal cord injury in rats
Hausmann, O., Fouad, K., Wallimann, T., & Schwab, M. (2002) · Spinal Cord · doi:10.1038/sj.sc.3101330 · Cited by 61
Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10
Brouillet, E., Henshaw, D. R., Schulz, J. B., & Beal, M. F. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90044-2 · Cited by 23
Cited by
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Liu, J. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9403-0 · Cited by 268
Long-term creatine supplementation is safe in aged patients with Parkinson disease
Bender, A., Samtleben, W., Elstner, M., & Klopstock, T. (2008) · Nutrition Research · doi:10.1016/j.nutres.2008.01.001 · Cited by 79
“In vitro and in vivo studies indicate neuroprotective effects of Cr in several animal models of neurodegenerative or acute neurologic diseases such as Huntington disease (HD), Parkinson disease (PD), amyotrophic lateral sclerosis (ALS), or ischemic stroke (for review [4]).”
Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders
Tarnopolsky, M. A. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_10 · Cited by 67
Self-citationCreatine monohydrate supplementation for older adults and clinical populations
Candow, D. G., Ostojic, S. M., Chilibeck, P. D., Longobardi, I., Gualano, B., Tarnopolsky, M. A., Wallimann, T., Moriarty, T., Kreider, R. B., Forbes, S. C., et al. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2025.2534130 · Cited by 43
Self-citation
Metadata
- Authors
- Baker, S. K., & Tarnopolsky, M. A.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2003-10
- Volume
- 12
- Issue
- 10
- Pages
- 1655-1679
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2095646768
- Cited by
- 43
- References
- 67
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.